Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Following publication of the GRAM study, the Wellcome Trust, Fleming Fund, and Bill and Melinda Gates Foundation hosted a webinar on 4 February 2022 to discuss the results, and the threat to global health posed by AMR.

This online launch event aimed to:

  • Explore these compelling new findings on the global burden of AMR and regional patterns and trends for over 88 pathogen-drug combinations
  • Celebrate the global collaboration and 100’s of data partnerships that made this study possible
  • Consider how data can be harnessed to support governments, health systems and civil society to act and reduce the human-cost of AMR
  • Identify immediate actions that can help countries around the world protect their health systems against the threat of AMR

Speakers and panellists included:

  • Dr Hanan Balkhy, Assistant Director-General for Antimicrobial Resistance, World Health Organization
  • Professor Dame Sally Davies, UK Special Envoy on AMR
  • Professor Christiane Dolecek, Senior Clinical Scientist,  University of Oxford
  • Dr Richard Horton, Editor-in-Chief, The Lancet
  • Dr Tim Jinks, Head of Intervention, Wellcome
  • Dr Mirfin Mpundu, Director, ReAct Africa
  • Professor Chris Murray, Director, Institute for Health Metrics and Evaluation
  • Dr Padmini Srikantiah, Deputy Director Pneumonia, Bill & Melinda Gates Foundation
  • Dr Pol Vandenbroucke, Chief Medical Officer, Pfizer

Read the publication 'Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis' on the Lancet website